Datametrex AI Limited (TSE:DM)
:DM
Top Page
Datametrex AI
(DM)
Select Model
Select Model
Rating:42Neutral
Price Target:
C$0.05
▼(-46.67% Downside)
Action:ReiteratedDate:03/21/26
The score is held down primarily by weak financial performance—heavy losses, negative margins, and ongoing cash burn—despite modest revenue growth and improved leverage. Technicals add further pressure with a clear bearish trend (below major moving averages and negative MACD), while valuation offers limited support because the company is unprofitable and provides no dividend yield.
Positive Factors
AI-focused business / structural tailwinds
The company’s core focus on applied AI and data-driven software aligns with durable industry demand for analytics and automation. Over a multi-month horizon this structural positioning supports sustained market opportunity and customer need for AI-enabled services if execution follows.
Negative Factors
Negative gross profit and deeply negative margins
Negative gross profit and an approximately -115% net margin reflect fundamental cost or pricing problems that undermine the business model. Without structural improvement to unit economics, revenue growth cannot translate into sustainable profits, threatening long-term viability.
Read all positive and negative factors
Positive Factors
Negative Factors
AI-focused business / structural tailwinds
The company’s core focus on applied AI and data-driven software aligns with durable industry demand for analytics and automation. Over a multi-month horizon this structural positioning supports sustained market opportunity and customer need for AI-enabled services if execution follows.
Read all positive factors
Datametrex AI (DM) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$7.63M
Dividend YieldN/A
Average Volume (3M)89.95K
Price to Earnings (P/E)―
Beta (1Y)3.02
Revenue Growth-56.02%
EPS Growth91.71%
CountryCA
Employees21
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)-0.02
Shares Outstanding152,586,000
10 Day Avg. Volume133,964
30 Day Avg. Volume89,955
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)0.63
Price to Sales (P/S)1.11
P/FCF Ratio-2.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Datametrex AI Business Overview & Revenue Model
Company Description
Datametrex AI Limited, together with its subsidiaries, provides collecting, analyzing, and presenting structured and unstructured data using its patented machine learning and artificial intelligence in Canada and South Korea. The company operates ...
How the Company Makes Money
null...
Datametrex AI Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
46
Neutral
Cash Flow
28
Negative
| Breakdown | Dec 2025 | Jun 2025 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.19M | 6.49M | 7.80M | 30.49M | 49.03M |
| Gross Profit | -695.90K | 3.07M | 2.17M | 10.20M | 21.03M |
| EBITDA | -4.48M | -1.24M | -6.95M | -13.46M | 13.29M |
| Net Income | -5.95M | -3.06M | -19.14M | -17.26M | 9.09M |
Balance Sheet | |||||
| Total Assets | 14.59M | 4.99M | 12.71M | 36.00M | 42.64M |
| Cash, Cash Equivalents and Short-Term Investments | 1.88M | 427.11K | 1.13M | 9.41M | 17.99M |
| Total Debt | 4.93M | 1.84M | 5.19M | 4.53M | 253.77K |
| Total Liabilities | 5.55M | 4.33M | 11.70M | 13.23M | 10.15M |
| Stockholders Equity | 9.05M | 656.40K | 1.00M | 22.77M | 32.49M |
Cash Flow | |||||
| Free Cash Flow | -2.83M | -1.57M | -6.94M | -2.28M | 11.42M |
| Operating Cash Flow | -2.83M | -1.22M | -5.62M | -249.09K | 11.45M |
| Investing Cash Flow | 32.51K | 59.10K | -969.15K | -3.79M | -234.41K |
| Financing Cash Flow | 4.18M | 1.21M | -254.18K | -2.40M | 2.19M |
Datametrex AI Technical Analysis
Negative
0.09
Price Trends
0.09
Negative
0.09
Negative
Market Momentum
>-0.01
Positive
39.78
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DM, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 39.78 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:DM.
Datametrex AI Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | C$45.11M | 0.46 | 45.36% | ― | 37.95% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | C$104.58M | 2.69 | -0.43% | ― | -59.23% | -100.34% | |
51 Neutral | C$130.08M | 60.68 | -13.00% | ― | 3.40% | -691.81% | |
42 Neutral | C$7.63M | -1.20 | -212.14% | ― | -56.02% | 91.71% | |
39 Underperform | C$5.17M | -15.43 | -3428.85% | ― | -15.33% | 47.13% |
* Technology Sector Average
TSE:DM
Datametrex AI
0.05
-0.03
-37.50%
TSE:KNR
Kontrol Technologies
2.50
0.00
0.00%
TSE:VIS
Visionstate
0.02
0.00
0.00%
TSE:ALYA
Alithya Group
1.34
-0.47
-25.97%
TSE:SPOT
GoldSpot Discoveries
0.33
0.15
85.71%
Datametrex AI Corporate Events
Business Operations and Strategy
Datametrex Subsidiary Licenses SoftPOS Patent Portfolio to AnywhereCommerce
Positive
Mar 19, 2026
Datametrex AI’s subsidiary Paymetrex has entered a royalty-bearing patent license agreement with payments firm AnywhereCommerce, covering Paymetrex’s U.S. and Canadian patents for secure transaction processing and mobile-based payment ...
Business Operations and StrategyProduct-Related Announcements
Datametrex Integrates AI Into EMR Platform to Ease Physician Workload
Positive
Mar 10, 2026
Datametrex AI has integrated new AI software into its electronic medical records system to assist physicians at the point of care, adding capabilities such as automated clinical documentation, intelligent document classification, real-time chartin...
Business Operations and Strategy
Datametrex’s Paymetrex Taps Pelent AI to Turbocharge Patent Licensing Push
Positive
Feb 23, 2026
Datametrex’s subsidiary Paymetrex has engaged Pelent Patent Analytics to embed Pelent’s specialized AI into its patent licensing workflow, aiming to better identify high-value licensing targets and unlock greater value from its IP port...
Business Operations and StrategyFinancial Disclosures
Datametrex Wins $1 Million Hyperconverged Infrastructure Order from Asian Fortune 500 Client
Positive
Feb 18, 2026
Datametrex AI Limited has secured a purchase order worth about $1 million from a large South Korea-based Fortune 500 conglomerate with diversified interests, primarily for Nutanix-based hyperconverged infrastructure software licenses. The deal, wh...
Business Operations and StrategyFinancial Disclosures
Datametrex Wins $500,000 Data Centre Order From South Korean Fortune 500 Client
Positive
Feb 13, 2026
Datametrex AI Limited has secured an approximately $500,000 purchase order from a South Korea-based Fortune 500 client for data centre operations and infrastructure solutions, carrying an estimated profit margin of about 20%. The mandate centers o...
Business Operations and Strategy
Datametrex’s Paymetrex Launches Patent Licensing Drive With First U.S. Deal
Positive
Feb 9, 2026
Datametrex’s subsidiary Paymetrex has launched a patent licensing program to monetize its portfolio of secure transaction processing and payment workflow technologies, signing its first non-exclusive U.S. licensing deal that will generate an...
Business Operations and StrategyFinancial Disclosures
Datametrex’s Paymetrex Lands First U.S. Patent Licensing Deal in Payments
Positive
Feb 9, 2026
Datametrex’s subsidiary Paymetrex has launched a patent licensing program to monetize its extensive payments and transaction-processing intellectual property, signing a first non-exclusive deal with a major U.S. payment solutions provider. T...
Business Operations and StrategyProduct-Related Announcements
Datametrex Deepens Push Into Hyperconverged Data Centre Infrastructure
Positive
Feb 4, 2026
Datametrex AI Limited is expanding its presence in modern data centre operations by deploying Nutanix-based hyperconverged infrastructure solutions that integrate servers, storage and networking into a single platform, following successful impleme...
Business Operations and Strategy
Datametrex Subsidiary Paymetrex Unveils Patent Licensing Drive in Mobile Payments
Positive
Feb 2, 2026
Datametrex AI’s subsidiary Paymetrex Payment Solutions has launched a patent licensing program to monetize its portfolio of U.S. and Canadian patents covering mobile and electronic payment technologies, some of which have been in place since...
Business Operations and Strategy
Datametrex AI to Court Investors at AlphaNorth Capital Event
Positive
Jan 15, 2026
Datametrex AI Limited will participate in the AlphaNorth Capital Event hosted by CEM from January 16–18, 2026, an investor-focused forum that connects growth-stage companies in resource, technology, biotech and special situations with capita...
Business Operations and StrategyFinancial Disclosures
Datametrex Wins $400,000 in New Orders, Strengthening Korean Growth Platform
Positive
Jan 8, 2026
Datametrex AI Limited has secured new purchase orders worth approximately CAD $400,000 through its wholly owned subsidiary, Datametrex Korea, reinforcing its role as a provider of IT infrastructure and technology solutions to large global enterpri...
Business Operations and StrategyProduct-Related Announcements
Datametrex’s Paymetrex Strikes Tech Deal with AnywhereCommerce to Expand Crypto-Enabled Payments
Positive
Jan 7, 2026
Datametrex AI’s subsidiary Paymetrex has signed a technology licensing agreement with U.S.-based payments orchestration firm AnywhereCommerce, gaining access to its suite of payment products and services to bolster Paymetrex’s YuzuPay-...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.